IMMU-12. PHASE I/II TRIAL OF IMMUNOTHERAPY WITH FUSIONS OF DENDRITIC CELLS AND TUMOR CELLS FOR RELAPSED OR REFRACTORY BRAIN TUMORS IN CHILDREN AND YOUNG ADULTS

BACKGROUND/OBJECTIVES: Relapsed or refractory brain tumors in childhood continue to have a dismal prognosis in spite of intensive multidisciplinary treatment. Cancer immunotherapy is newly developed to be expected as next promising treatment for highly aggressive pediatric cancer. This trial was des...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Neuro Oncol
Päätekijät: Yamaoka, Masayoshi, Akasaki, Yasuharu, Takei, Jun, Akiyama, Masaharu, Tasaki, Tetsunori, Ohashi, Toya, Ida, Hiroyuki, Yanagisawa, Takaaki
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Oxford University Press 2020
Aiheet:
Immunotherapy
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7715224/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa222.368
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia